NYA TRIAZOLPYRIMIDINER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING

NYA TRIAZOLPYRIMIDINER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING

s-triazolo(1,5-a)pyrimidine compounds of the Formula (I> wherein R2 and R3 are the same or different and represent an H atom, a C1 to C3 alkyl group or a halogen atom; R4 represents a straight-chain or branched-chain C4 to C9 alkyl group, an aralkyl group substituted by one or more C1 to C3 alkox...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: 1)M BALLNUS, 12)E-G KRAUSE, 2)E TENOR, 13)B SCHUBERT, 3)E THOMAS, 8)I HEINROTH, 11)R BODEWEI, 10)S HERING, 5)H-J MEST, 9)G KONETZKE, 4)R PASCHE, 6)H-U BLOCK, 7)P MENTZ
Format: Patent
Sprache:swe
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:s-triazolo(1,5-a)pyrimidine compounds of the Formula (I> wherein R2 and R3 are the same or different and represent an H atom, a C1 to C3 alkyl group or a halogen atom; R4 represents a straight-chain or branched-chain C4 to C9 alkyl group, an aralkyl group substituted by one or more C1 to C3 alkoxy or alkyl groups; 2,5-dioxaheptyl or 3-oxahexyl residues; R5 represents an H atom, a C1 to C3 alkyl group, a hydroxyethyl group or a hydroxypropyl group; R6 and R7 are the same or different and represent an H atom, a straight-chain or branched-chain C1 to C5 alkyl group, or R6 and R7 together complete a cycloaliphatic ring, the substituents in positions 5 and 7 optionally being mutually exchanged, and the pharmaceutically acceptable salts thereof, their preparation and pharmaceutical compositions comprising them are disclosed as therapeutic aids for cardio-circulatory disorder.